Product Images Sotalol Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Sotalol Hydrochloride NDC 71610-074 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 80 mg - 71610 0074 30

Sotalol HCI (AF) is a prescription medication that comes in the form of 30 tablets containing 80mg each. The National Drug Code (NOC) number for this medication is 71610007430.*
Figure1.jpg - Figure1

This appears to be a table or graph comparing the recurrence-free survival of Sotalol Hydrochloride Tahlats (AF) versus a placebo at different doses. The results are presented using the Log-Rank method and values of 0.225, 0.012, and 0.029 are given for different doses. The X-axis appears to represent time in days. However, without additional context, it is not clear what condition or illness this analysis pertains to.*
Figure2.jpg - Figure2

This is a graphical representation of Recurrence-Free Survival for patients taking Sotalol Hydrochloride Tablets (for Atrial Fibrillation) compared to Placebo. The graph shows the time in days (up to 180) on the X-axis and the percentage of patients who were recurrence-free on the Y-axis. A P-value of 0.002 was obtained using the Log-Rank test, suggesting that the use of Sotalol Hydrochloride Tablets has an effect on recurrence-free survival compared to Placebo.*
age factor - sotalolhcl af 04

This text defines the age factor as 1 for an age greater than 24 months. It also includes a label for age in months.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.